January 7, 2013
Marinus Pharmaceuticals announced $21 million in new Series C financing from U.S. venture capital firm Domain Associates, LLC, Rusnano subsidiary RusnanoMedInvest (RMI), and co-investors.
RUSNANO and Domain Associates announced their first joint investment under a joint agreement reached in March. They will jointly invest in nearly $40 million in San Diego-based CoDa Therapeutics.
RUSNANO and Domain Associates announced a partnership that will spur modernization of the Russian healthcare market by brining next-generation pharmaceuticals, medical devices and diagnostics to Russia.